Mdma molecule:

Image from PubChem

Mdma Clinical Trials


To see complete record on clinicaltrials.gov, please visit this link

Id: NCT00838305

Organisation Name: California Pacific Medical Center Research Institute

Overal Status: Completed

Start Date: February 2009

Last Update: May 31, 2013

Lead Sponsor: California Pacific Medical Center Research Institute

Brief Summary: The purpose of this study is to measure the effects of MDMA (particularly its emotional effects) and to determine the role of serotonin in these effects. Serotonin is a neurotransmitter, which is a chemical that is released by some brain cells to communicate with other brain cells. Many of the effects of MDMA are thought to be the result of increased serotonin release.

In order to understand the effects of MDMA and role of serotonin in these effects, we will administer MDMA alone and in combination with the antidepressant citalopram (one trade name for this is Celexa). Citalopram decreases the ability of MDMA to release serotonin. Citalopram will therefore decrease any of MDMA's effects that are the result of serotonin release; we want to measure this.

Conditions:
  • MDMA Mechanism of Action


Total execution time in seconds: 0.19180083274841